About PepGel
PepGel is a company based in Manhattan (United States) founded in 2012. PepGel offers products and services including PGmatrix, BioInk, and PGmatrix-hiPSC Hybrid. PepGel operates in a competitive market with competitors including Biogelx, Gel Coat Biomaterials, SPES Tech, Matrix Bio and Sumatrix Biotech, among others.
- Headquarter Manhattan, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pepgel Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$270 K (USD), Grant
Jul 01, 2013
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PepGel
PepGel offers a comprehensive portfolio of products and services, including PGmatrix, BioInk, and PGmatrix-hiPSC Hybrid.
Hydrogel for 3D cell cultures and drug discovery applications.
Material for 3D printing and live cell manufacturing.
System for scalable somatic cell production from hiPSCs.
Funding Insights of PepGel
Investors in PepGel
PepGel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for PepGel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PepGel
Investment portfolio details for PepGel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PepGel
Detailed financials for PepGel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pepgel Comparisons
Peer comparison for PepGel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PepGel
PepGel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogelx, Gel Coat Biomaterials, SPES Tech, Matrix Bio and Sumatrix Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Peptide hydrogels and preparation protocols are supplied for cell culture.
|
|
| Locked | Locked | Locked |
Hydrogel technology is developed for biomaterials and medical uses.
|
|
| Locked | Locked | Locked |
Develops recombinant protein hydrogel technology for cell culture applications.
|
|
| Locked | Locked | Locked |
Develops AI tools for optimizing hydrogels in 3D cell culture research.
|
|
| Locked | Locked | Locked |
Produces high-quality hydrogel materials for various applications.
|
Detailed competitors of PepGel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pepgel
Complete news archive for PepGel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PepGel
PepGel was founded in 2012 and raised its 1st funding round 1 year after it was founded.
PepGel is headquartered in Manhattan, United States. It is registered at Manhattan, New York, United States.
Founded in 2012 as a spin-out from Kansas State University, PepGel is headquartered in Manhattan, United States, within the biotechnology sector. Self-healing hydrogels are produced using a proprietary synthetic peptide platform comprising 19 amino acid residues, which facilitates transitions between liquid and gel states. The flagship PGMatrix product is offered in a pre-mixed, no-chill format for applications in cancer and stem cell line development for research purposes.
PepGel's top competitors include Biogelx, Gel Coat Biomaterials and SPES Tech.
PepGel offers PGmatrix, BioInk, and PGmatrix-hiPSC Hybrid.
PepGel has 1 investor. Key investors include National Science Foundation.